SKYTROFA is now FDA approved for adults with growth hormone deficiency Learn More
SKYTROFA Difference Photo SKYTROFA Difference Photo

The SKYTROFA Difference

SKYTROFA is the first FDA-approved once-weekly treatment for pediatric GHD that delivers somatropin, which is used in daily growth hormone therapies.

auto-injector girl photo

What is SKYTROFA?

Once-weekly SKYTROFA:

  • Is used to treat pediatric growth hormone deficiency (GHD) in children aged 1 year and older who weigh at least 11.5 kg (25.35 lb)
  • Provides somatropin, which is used in daily growth hormone injections
  • Was designed to deliver your child’s medicine with extended-release technology
  • Has an established safety profile

Features of SKYTROFA

injection free days icon

More injection-free days compared with daily therapies

no refrigeration Icon

Convenient storage with no required refrigeration for up to 6 months* and preservative free

higher growth rate icon

Higher growth rate after 1 year in a clinical trial compared with a daily somatropin therapy†

clinical data icon

Clinical data for pediatric patients switching from a daily somatropin to SKYTROFA‡

*Store SKYTROFA in the original package to protect from light. Do not freeze. SKYTROFA can be stored at room temperature (not to exceed 86°F [30°C]) for up to 6 months. Alternatively, SKYTROFA can be stored under refrigeration at 36°F to 46°F (2°C to 8°C) until the expiration date. If refrigerated, keep at room temperature for 15 minutes before use. Do not use SKYTROFA beyond the expiration date or 6 months after the date it was first removed from refrigeration (whichever is earlier).
†In a clinical trial that compared once-weekly SKYTROFA with a daily somatropin in 161 children with pediatric growth hormone deficiency (GHD) who previously had not been on treatment. The primary endpoint from the clinical trial was annualized height velocity (AHV) at 52 weeks.
‡SKYTROFA was studied in a 26-week clinical trial investigating the safety, tolerability, and efficacy of SKYTROFA administered once weekly in children with pediatric GHD. The trial included 3 children who previously had not been on treatment and 143 children previously treated with daily growth hormone therapies for ≤ 130 weeks. Safety and tolerability were the primary endpoints.
how SKYTROFA works photo

How SKYTROFA works:

Long-acting, extended release

The innovative technology of SKYTROFA makes once-weekly dosing possible for you and your child.

SKYTROFA delivers somatropin, which is used in daily growth hormone therapies. After your child’s SKYTROFA injection, somatropin slowly begins to release over time. This means that your child will get the medicine they need to grow from their injection over the course of a week.

SKYTROFA safety profile photo

Established safety profile

Once-weekly SKYTROFA is FDA approved, with an established safety profile.

  • In a clinical study, some children taking once-weekly SKYTROFA had mild injection-site reactions
  • Side effects occurring more frequently than with daily somatropin included viral infection, fever, cough, nausea and vomiting, bleeding, diarrhea, stomach area pain, and joint pain and arthritis

Get to know SKYTROFA!

Learn more about what to expect when using once-weekly SKYTROFA

Download Brochure
SKYTROFA Ambassador Photo
Real caregiver of child with GHD

Meet Lezette

Every SKYTROFA journey is unique. See how Lezette and her son, Christian, are busy with his soccer season, and how he schedules his weekly SKYTROFA.

Lezette’s Story

IMPORTANT SAFETY INFORMATION & USES

SKYTROFA is a prescription medicine used for:

  • the replacement of growth hormone in children 1 year old or older who weigh at least 26 pounds (11.5 kilograms) with growth hormone deficiency (GHD)
  • the replacement of growth hormone in adults with growth hormone deficiency (GHD)

Do not take SKYTROFA if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
  • you are allergic to somatropin or any of the ingredients in SKYTROFA

IMPORTANT SAFETY INFORMATION & USES

SKYTROFA is a prescription medicine used for:

  • the replacement of growth hormone in children 1 year old or older who weigh at least 26 pounds (11.5 kilograms) with growth hormone deficiency (GHD)
  • the replacement of growth hormone in adults with growth hormone deficiency (GHD)

Do not take SKYTROFA if:

  • you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing problems
  • you are allergic to somatropin or any of the ingredients in SKYTROFA
  • you are a child with closed bone growth plates
  • you have cancer or other tumors
  • you have certain types of eye problems caused by diabetes
  • you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea (briefly stopping breathing during sleep)

Tell your healthcare provider if you are pregnant or plan to become pregnant, about all of your medical conditions, and about all the medicines you take. SKYTROFA may affect how other medicines work, and other medicines may affect how SKYTROFA works.

What are the possible side effects of SKYTROFA?

SKYTROFA may cause serious side effects, including:

  • serious allergic reactions. Get medical help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing
  • high risk of death in people who have critical illnesses caused by heart or stomach surgery, trauma, or serious breathing problems
  • increased risk of growth of an existing tumor or cancer, or increased risk of a previous tumor or cancer returning in people who were treated with radiation to the brain or head as children and who developed low growth hormone problems. Your healthcare provider will need to monitor for the growth or return of a tumor or cancer. Contact your healthcare provider if you start to have sudden changes in behavior, headaches, vision problems, or changes in moles, birthmarks, or skin color
  • new or worsening high blood sugar or diabetes. Your blood sugar may need to be monitored during treatment with SKYTROFA
  • increase in pressure in the skull. Contact your healthcare provider if headaches, eye problems, nausea, or vomiting occur
  • too much fluid in the body (fluid retention). Contact your healthcare provider if you notice swelling in the hands and feet, pain in the joints or muscles, or nerve problems that cause pain, burning or tingling in the hands, arms, legs, and feet
  • decrease in a hormone called cortisol. Your healthcare provider will do blood tests to check your cortisol levels
  • decrease in thyroid hormone levels. Decreased thyroid hormone levels may affect how well SKYTROFA works. Your healthcare provider will do blood tests to check your thyroid hormone levels
  • hip and knee pain or a limp in children (slipped capital femoral epiphysis). This may lead to a serious condition where bone tissue dies due to a lack of blood supply (osteonecrosis). Get medical help right away for children who develop a limp or have hip or knee pain
  • worsening of curvature of the spine in children (scoliosis)
  • severe and constant abdominal pain. This could be a sign of pancreatitis. Tell your healthcare provider about any new abdominal pain
  • loss of fat and tissue weakness in the area of skin you or your child inject. Talk to your healthcare provider about rotating the areas where SKYTROFA is injected
  • high risk of sudden death in children with Prader-Willi syndrome who are severely obese or have breathing problems, including sleep apnea
  • increase in phosphate, alkaline phosphatase, and parathyroid hormone levels in your blood. Your healthcare provider will do blood tests to check this

The most common side effects of SKYTROFA in children include: viral infection, fever, cough, nausea and vomiting, bleeding, diarrhea, stomach area pain, joint pain and arthritis

The most common side effects of SKYTROFA in adults include: swelling due to fluid build-up and low thyroid hormone

These are not all of the possible side effects of SKYTROFA. Call your doctor for medical advice about side effects. You are encouraged to report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. You may also report side effects to Ascendis Pharma at 1-844-442-7236.

Please click here for SKYTROFA full Prescribing Information.

+
Skytrofa in stock

SKYTROFA® is now covered
by more insurance plans!

Check your coverage today